Page last updated: 2024-08-18

arginine vasopressin and cyclosporine

arginine vasopressin has been researched along with cyclosporine in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (56.25)18.2507
2000's3 (18.75)29.6817
2010's4 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hardy, KJ; Phillips, PA; Potocnik, SJ1
Braith, RW; Limacher, MC; Lowenthal, DT; Phillips, MI; Pollock, ML; Staples, ED; Wood, CE1
Bronsther, O; Brown, MR; Crum, R; Dominic, W; Fairchild, R; Fernandez, R; Ward, D1
Dominice, C; Dufour, MN; Grazzini, E; Guillon, G; Jouin, P; Manzoni, O; Patino, N1
Bokemeyer, D; Drechsler, S; Friedrichs, U; Kramer, HJ; Meyer-Lehnert, H1
Eckert, B; Knepel, W; Schwaninger, M1
Braith, RW; Davis, GL; Mills, RM; Wilcox, CS; Wood, CE1
Byrnes, AP; Conde, G; Geddes, BJ; Harding, TC; Hughes, DS; Lightman, SL; Uney, JB1
Thomas, M; Tyagi, MG1
Brandis, M; Epting, T; Fischer-Riepe, P; Gordjani, N; Greger, RF; Leipziger, J; Nitschke, R1
Avdonin, PV; Buetler, TM; Cottet-Maire, F; Mermod, N; Roulet, E; Ruegg, UT1
Shang, FJ; Wang, JP; Zhao, LY; Zheng, QS1
Bachmann, S; Bader, M; Blankenstein, KI; Boldt, C; Borschewski, A; Ellison, DH; Labes, R; McCormick, JA; Mutig, K; Paliege, A1

Reviews

1 review(s) available for arginine vasopressin and cyclosporine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

15 other study(ies) available for arginine vasopressin and cyclosporine

ArticleYear
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Human resistance artery reactivity is altered by liver transplantation and treatment with cyclosporin A.
    Transplantation proceedings, 1992, Volume: 24, Issue:5

    Topics: Adipose Tissue; Angiotensin II; Arginine Vasopressin; Arteries; Cyclosporine; Humans; In Vitro Techniques; Liver Neoplasms; Liver Transplantation; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Vascular Resistance; Vasoconstriction

1992
Abnormal neuroendocrine responses during exercise in heart transplant recipients.
    Circulation, 1992, Volume: 86, Issue:5

    Topics: Afferent Pathways; Arginine Vasopressin; Atrial Natriuretic Factor; Cyclosporine; Exercise; Exercise Test; Female; Heart; Heart Transplantation; Humans; Hypertension; Kidney; Male; Mechanoreceptors; Middle Aged; Neurosecretory Systems; Norepinephrine; Renin-Angiotensin System

1992
Neuroendocrinology of chronic renal failure and renal transplantation.
    Transplantation, 1991, Volume: 52, Issue:5

    Topics: Adult; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Cyclosporine; Epinephrine; Furosemide; Humans; Hypertension, Renal; Kidney Failure, Chronic; Kidney Transplantation; Methylprednisolone; Neurosecretory Systems; Norepinephrine; Prospective Studies; Radioimmunoassay; Renal Dialysis; Water-Electrolyte Balance

1991
Dual effects of nordidemnin on WRK1 cells: inhibition of phosphoinositide metabolism and cell proliferation.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Arginine Vasopressin; Calcium; Cell Division; Cyclosporine; Depsipeptides; Female; Inositol; Peptides, Cyclic; Phosphatidylinositols; Rats; Tumor Cells, Cultured; Type C Phospholipases

1994
Cellular signaling by cyclosporine A in contractile cells: interactions with atrial natriuretic peptide.
    The Clinical investigator, 1993, Volume: 71, Issue:2

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Calcium; Cells, Cultured; Cyclosporine; Glomerular Mesangium; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Signal Transduction

1993
Calcium-mobilizing insulin secretagogues stimulate transcription that is directed by the cyclic adenosine 3',5'-monophosphate/calcium response element in a pancreatic islet beta-cell line.
    Endocrinology, 1996, Volume: 137, Issue:1

    Topics: Animals; Arginine Vasopressin; Biological Transport; Calcium; Cell Line; Cricetinae; Cyclic AMP Response Element-Binding Protein; Cyclosporine; Insulin; Insulin Secretion; Islets of Langerhans; Phosphorylation; Tacrolimus; Transcription, Genetic

1996
Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients.
    Journal of the American College of Cardiology, 1996, Volume: 27, Issue:2

    Topics: Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Case-Control Studies; Cyclosporine; Female; Heart; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Renin-Angiotensin System; Sodium Chloride; Sodium, Dietary; Ventricular Function, Left; Water-Electrolyte Balance; Water-Electrolyte Imbalance

1996
Persistent transgene expression in the hypothalamus following stereotaxic delivery of a recombinant adenovirus: suppression of the immune response with cyclosporin.
    Endocrinology, 1996, Volume: 137, Issue:11

    Topics: Adenoviruses, Human; Animals; Arginine Vasopressin; beta-Galactosidase; Cell Line; Cyclosporine; Gene Expression; Genes, Reporter; Humans; Immunosuppression Therapy; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Inbred WKY; Stereotaxic Techniques; Transfection

1996
Enhanced cardiovascular reactivity to desmopressin in water-restricted rats: facilitatory role of immunosuppression.
    Methods and findings in experimental and clinical pharmacology, 1999, Volume: 21, Issue:9

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiovascular System; Cyclosporine; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Drug Synergism; Heart Rate; Hemodynamics; Immunosuppression Therapy; Immunosuppressive Agents; Infusions, Intra-Arterial; Infusions, Intravenous; Rats; Tacrolimus; Time Factors; Water Deprivation

1999
Cyclosporin-A-induced effects on the free Ca2+ concentration in LLC-PK1-cells and their mechanisms.
    Pflugers Archiv : European journal of physiology, 2000, Volume: 439, Issue:5

    Topics: Adenosine Triphosphate; Animals; Arginine Vasopressin; Biological Transport; Calcineurin Inhibitors; Calcium; Cyclosporine; Estrenes; Fluorescent Dyes; Fura-2; Immunosuppressive Agents; Inositol 1,4,5-Trisphosphate; Kidney Tubules, Proximal; LLC-PK1 Cells; Nicardipine; Phosphodiesterase Inhibitors; Pyrrolidinones; Renal Agents; Signal Transduction; Swine; Tacrolimus; Type C Phospholipases; Vasodilator Agents

2000
Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment.
    British journal of pharmacology, 2001, Volume: 132, Issue:4

    Topics: Animals; Arginine Vasopressin; Cells, Cultured; Cyclosporine; Heterogeneous Nuclear Ribonucleoprotein D0; Heterogeneous-Nuclear Ribonucleoprotein D; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred WKY; Receptors, Vasopressin; RNA-Binding Proteins; RNA, Messenger; Up-Regulation

2001
Inhibitory effect of cyclosporin A on growth and collagen synthesis of rat cardiac fibroblasts induced by arginine vasopressin.
    Yao xue xue bao = Acta pharmaceutica Sinica, 2006, Volume: 41, Issue:11

    Topics: Animals; Animals, Newborn; Arginine Vasopressin; Calcineurin; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Collagen; Cyclosporine; Dose-Response Relationship, Drug; Fibroblasts; Hydroxyproline; Myocardium; Rats; Rats, Sprague-Dawley

2006
Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms.
    American journal of physiology. Renal physiology, 2017, 03-01, Volume: 312, Issue:3

    Topics: Animals; Arginine Vasopressin; Calcineurin Inhibitors; Cells, Cultured; Cyclooxygenase 2; Cyclosporine; Epithelial Cells; Hypertension; Immunosuppressive Agents; Kidney Tubules, Distal; Loop of Henle; Male; Rats, Brattleboro; Rats, Wistar; Renin; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Time Factors; Water-Electrolyte Balance

2017